IFP Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRWD
AC
SCM
IFP Advisors's IRWD Position: Q2 2026 in Review
IFP Advisors reduced its Ironwood Pharmaceuticals (IRWD) stake by 43% in Q2 2026, selling an estimated $6.62K and leaving 2,316 shares worth $9.75K. The position accounts for ﹤0.01% of the portfolio, ranked #3409.
IFP Advisors first reported a position in IRWD in Q2 2017 and has held it in 19 quarters since. The position peaked at $38K in Q4 2022. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.
- IFP Advisors held 2,316 shares of Ironwood Pharmaceuticals worth $9.75K as of Q2 2026.
- IFP Advisors sold 1,717 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $6.62K.
- Ironwood Pharmaceuticals made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3409 holding.
- IFP Advisors first reported a position in Ironwood Pharmaceuticals in Q2 2017 and has held it in 19 quarters since.
- IFP Advisors's Ironwood Pharmaceuticals position peaked at $38K in Q4 2022.
- 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.
Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.